Back to News
Market Impact: 0.35

Pelthos Therapeutics Inc. (PTHS) Reports Q4 Loss, Tops Revenue Estimates

PTHS
Corporate EarningsCompany FundamentalsHealthcare & BiotechAnalyst Estimates

Pelthos reported a Q loss of $2.83 per share versus the Zacks consensus loss of $3.95, beating estimates by $1.12. The loss narrowed from $3.20 a year ago (an improvement of $0.37, ~11.6%). The result is a modest positive for the equity given the earnings beat, though not a market-moving development.

Analysis

Pelthos reported a Q loss of $2.83 per share versus the Zacks consensus loss of $3.95, beating estimates by $1.12. The loss narrowed from $3.20 a year ago (an improvement of $0.37, ~11.6%). The result is a modest positive for the equity given the earnings beat, though not a market-moving development.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Demo

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.28

Ticker Sentiment

PTHS0.28